Ash Cooper
MicroRNA Revolution: Tiny Molecules, Big Impact on Diagnostics and Precision Medicine
When the first microRNAs (miRNAs) were linked to gene‑silencing more than two decades ago, few foresaw how profoundly these 20–25‑nucleotide regulators would transform life science. Today, miRNAs inform everything from basic cell‑biology experiments to multi‑site clinical trials and point‑of‑care diagnostic devices. In an exclusive interview with News‑Medical, Dr. Lohit Khera—Head of Scientific Sales at Canadian biotech firm Norgen Biotek—explains how advances in RNA extraction, automation, and artificial intelligence (AI) are accelerating the move from discovery to routine clinical deployment.
· 6 min read

